-
Emily Liu
Spark Therapeutics Inc, Philadelphia, Pennsylvania, United States
-
Joshua Boyer
Spark Therapeutics Inc, Philadelphia, Pennsylvania, United States
-
Rachel M. Huckfeldt
Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
-
Elise Heon
Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada
-
Paul F Kenna
Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland
Ocular Genetics Unit, The University of Dublin Trinity College, Dublin, Ireland
-
Isabelle Audo
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, Île-de-France, France
-
Ruifang Sui
Department of Ophthalmology, Peking Union Medical College Hospital, Dongcheng-qu, Beijing, China
-
Elias I Traboulsi
Ophthalmology, Cleveland Clinic, Cleveland, Ohio, United States
-
Paul S Bernstein
Ophthalmology and Visual Sciences, Clincal and Basic Science Research, Moran Eye Center, The University of Utah School of Medicine, Salt Lake City, Utah, United States
-
Tim Stout
Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, United States
-
Kathy Reape
Spark Therapeutics, Inc. (Formerly), Pennsylvania, United States
-
Daniel C Chung
Spark Therapeutics Inc, Philadelphia, Pennsylvania, United States